It appeared that StAR mutations with more than 10–20% of wt activity in vitro may rather manifest as NCLAH (or FGD) while an activity of less than 10% may be found with severe forms of CLAH. The gene discussed is STAR; the disease is congenital lipoid adrenal hyperplasia due to STAR deficency.